Hudson Value Partners LLC Trims Stock Position in Azenta, Inc. $AZTA

Hudson Value Partners LLC decreased its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 19.1% during the second quarter, Holdings Channel reports. The institutional investor owned 7,870 shares of the company’s stock after selling 1,860 shares during the period. Hudson Value Partners LLC’s holdings in Azenta were worth $242,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Azenta by 8.9% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 4,842 shares of the company’s stock valued at $168,000 after acquiring an additional 396 shares during the last quarter. Farther Finance Advisors LLC boosted its position in shares of Azenta by 41.6% during the 2nd quarter. Farther Finance Advisors LLC now owns 1,371 shares of the company’s stock valued at $42,000 after acquiring an additional 403 shares during the last quarter. Empowered Funds LLC boosted its position in shares of Azenta by 10.5% during the 1st quarter. Empowered Funds LLC now owns 6,482 shares of the company’s stock valued at $225,000 after acquiring an additional 618 shares during the last quarter. Oppenheimer Asset Management Inc. boosted its position in shares of Azenta by 6.4% during the 1st quarter. Oppenheimer Asset Management Inc. now owns 12,617 shares of the company’s stock valued at $437,000 after acquiring an additional 756 shares during the last quarter. Finally, Quarry LP boosted its position in shares of Azenta by 41.5% during the 1st quarter. Quarry LP now owns 3,120 shares of the company’s stock valued at $108,000 after acquiring an additional 915 shares during the last quarter. Institutional investors own 99.08% of the company’s stock.

Azenta Stock Up 10.0%

Shares of AZTA opened at $31.58 on Thursday. The company has a market cap of $1.45 billion, a PE ratio of -13.05 and a beta of 1.63. The business has a fifty day moving average of $30.48 and a 200 day moving average of $30.08. Azenta, Inc. has a 52-week low of $23.91 and a 52-week high of $55.63.

Azenta (NASDAQ:AZTA) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.13 by $0.06. The company had revenue of $143.94 million during the quarter, compared to the consensus estimate of $149.64 million. Azenta had a positive return on equity of 1.35% and a negative net margin of 18.45%.Azenta’s revenue was up .0% on a year-over-year basis. During the same period last year, the company earned $0.14 earnings per share. As a group, research analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on AZTA. Stephens began coverage on Azenta in a research report on Tuesday, July 22nd. They set an “equal weight” rating and a $35.00 target price for the company. Evercore ISI set a $33.00 target price on Azenta and gave the company an “in-line” rating in a research report on Tuesday, August 5th. Finally, Raymond James Financial upgraded Azenta from a “market perform” rating to an “outperform” rating and set a $35.00 target price for the company in a research report on Wednesday, August 6th. Two investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Azenta currently has a consensus rating of “Hold” and an average target price of $35.75.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.